Provided by Tiger Trade Technology Pte. Ltd.

DaVita HealthCare Partners

177.02
+0.24000.14%
Post-market: 176.00-1.0200-0.58%16:42 EDT
Volume:582.20K
Turnover:103.10M
Market Cap:11.36B
PE:14.59
High:179.03
Open:176.58
Low:175.41
Close:176.78
52wk High:247.49
52wk Low:101.00
Shares:64.20M
Float Shares:32.63M
Volume Ratio:1.13
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.13
EPS(LYR):9.84
ROE:88.48%
ROA:7.51%
PB:-14.85
PE(LYR):17.99

Loading ...

Movement Alert|DaVita HealthCare Partners Falls 5.01% in Regular Trading, Unchanged Full-Year Guidance and Berkshire Stake Reduction Continue to Weigh

Market Focus
·
Aug 07

Akebia Q2 Revenue Falls on Lower Auryxia Sales

Reuters
·
Aug 06

Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today

Benzinga_recent_news
·
Aug 06

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 06

Movement Alert|DaVita HealthCare Partners Falls 17.34% in Regular Trading, Guidance Unchanged Despite Q2 Beat Combined with Berkshire Selling

Market Focus
·
Aug 05

DaVita Down over 16%, on Pace for Largest Percent Decrease Since October 2023

Dow Jones
·
Aug 05

BofA Adjusts Price Target on DaVita to $170 From $145

MT Newswires Live
·
Aug 05

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Syndax Pharmaceuticals (SNDX) and DaVita (DVA)

TIPRANKS
·
Aug 05

U.S. Stocks on the MOVE-Arista Networks, CVS, Eli Lilly, Phillips 66

Reuters
·
Aug 05

DaVita, Inc. : Deutsche Bank Raises Target Price to $265 from $220

THOMSON REUTERS
·
Aug 05

CVS Health Q2 Revenue Beats Estimates, Outlook Raised

Reuters
·
Aug 05

Movement Alert|DaVita HealthCare Partners Falls 5.94% in Pre-Market Trading, Q2 Beat Overshadowed by Unchanged Full-Year Guidance

Market Focus
·
Aug 05

Barclays Sticks to Its Hold Rating for DaVita (DVA)

TIPRANKS
·
Aug 05

Movement Alert|DaVita HealthCare Partners Declines 5.83% Overnight, Q2 Beat Overshadowed by Unchanged Full-Year Guidance

Market Focus
·
Aug 05

Stock Track | DaVita HealthCare Partners Plunges 5.83% in Post-Market as Unchanged Full-Year Guidance Disappoints Despite Q2 Beat

Stock Track
·
Aug 05

DaVita Flags Lower Revenue Per Treatment, Reaffirms Annual Forecast

Reuters
·
Aug 05

DaVita Q2 FY26 Operating Income Climbs 20.1% to $579 Million; Revenue Rises 4% to $3.55 Billion

Reuters
·
Aug 05

DaVita Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Berkshire Sells 182,980 DaVita Shares, Still Has 45% Stake in Dialysis Provider

Reuters
·
Aug 05

Berkshire Hathaway Sells 182,980 DaVita Shares at an Average $199.55 Each, Still Owns About 28.7 Million DaVita Shares, SEC Filing Shows

THOMSON REUTERS
·
Aug 05